Onkure Therapeutics, INC. (OKUR) SEC Filings — 2024
30 SEC filings for Onkure Therapeutics, INC. (OKUR) in 2024.
Filings
- OnKure Therapeutics Files 8-K: Corporate Details Updated — 8-K · Dec 10, 2024
- Onkure Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Onkure Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- OnKure Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Onkure Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 28, 2024
- OnKure Therapeutics Files for IPO — S-1 · Oct 23, 2024
- Onkure Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 23, 2024
- Onkure Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 16, 2024
- Onkure Therapeutics, INC. SC 13G Filing — SC 13G · Oct 11, 2024
- Onkure Therapeutics, INC. SC 13G Filing — SC 13G · Oct 11, 2024
- Onkure Therapeutics, INC. SC 13G Filing — SC 13G · Oct 11, 2024
- Carlyle Group Files 13D/A Amendment for OnKure Therapeutics — SC 13D/A · Oct 10, 2024
- Onkure Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 9, 2024
- Onkure Therapeutics, INC. SC 13G Filing — SC 13G · Oct 9, 2024
- OnKure Therapeutics Files 8-K on Asset Deal & Equity Sales — 8-K · Oct 8, 2024
- NEA 15 Amends 13D Filing for OnKure Therapeutics — SC 13D/A · Oct 8, 2024
- Reneo Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Oct 2, 2024
- Reneo Pharmaceuticals, INC. SC 13G Filing — SC 13G · Sep 26, 2024
- Reneo Pharmaceuticals to be Acquired by Syncona Limited — 8-K · Sep 20, 2024
- Reneo Pharmaceuticals Announces Board and Executive Changes — 8-K · Sep 13, 2024
- Reneo Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Reneo Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · May 21, 2024
- Reneo Pharmaceuticals Announces Definitive Agreement, Equity Sales — 8-K · May 13, 2024
- NEA 15 Amends Reneo Pharma Stake Filing — SC 13D/A · May 8, 2024
- Reneo Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Reneo Pharmaceuticals Files 10-K/A Amendment — 10-K/A · Apr 26, 2024
- Reneo Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Reneo Pharma Reports Exit/Disposal Costs, Signals Strategic Shift — 8-K · Feb 23, 2024
- Octagon Capital Advisors Discloses 2.25M Share Stake in Reneo Pharma — SC 13G · Feb 5, 2024
- BML Investment Partners Takes 5.0% Stake in Reneo Pharma — SC 13G · Jan 17, 2024